| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 07/02/2020 | 17h32 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 05/02/2020 | 16h47 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 09/01/2020 | 14h00 | PR Newswire (US) | Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 17/12/2019 | 12h00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 11/12/2019 | 22h46 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 11/12/2019 | 22h40 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 11/12/2019 | 22h36 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 11/12/2019 | 22h29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 11/12/2019 | 22h23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 11/12/2019 | 12h11 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 15/11/2019 | 15h07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 14/11/2019 | 22h05 | GlobeNewswire Inc. | Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 14/11/2019 | 14h30 | GlobeNewswire Inc. | Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting Notice | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 12/11/2019 | 22h42 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 17/10/2019 | 15h01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 07/10/2019 | 14h30 | GlobeNewswire Inc. | Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove L... | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 04/10/2019 | 20h11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 23/09/2019 | 15h03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 17/09/2019 | 14h46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 17/09/2019 | 14h30 | GlobeNewswire Inc. | Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 14/08/2019 | 22h09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 08/08/2019 | 22h45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 08/08/2019 | 22h43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 08/08/2019 | 22h41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 08/08/2019 | 22h40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 08/08/2019 | 22h19 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 05/08/2019 | 15h05 | GlobeNewswire Inc. | Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 03/07/2019 | 19h48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 03/07/2019 | 19h43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
| 03/07/2019 | 19h40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SNNA | Sienna Biopharmaceuticals Inc |
